Biocon Pharma gets USFDA nod for deep vein thrombosis drug Rivaroxaban Ruchika Sharma16 May 2025 2:57 PM ISTBangalore: Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received approval for its Abbreviated New Drug...
Lupin Rivaroxaban Tablets approved by USFDA Ruchika Sharma16 May 2025 12:23 PM ISTMumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated...
Aurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis drug Rivaroxaban Ruchika Sharma14 April 2025 11:30 AM ISTAurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and...
Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs Ruchika Sharma5 March 2025 11:30 AM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...
Elevated Biomarkers Predict Long-Term Mortality Risks in Patients with Suspected Pulmonary Embolism: Study Medha Baranwal26 Sept 2024 8:15 PM ISTFinland: Recent research, published in the European Heart Journal Open has highlighted the critical role of several biomarkers-D-dimer, cardiac...
Frequent and Severe COPD Exacerbations Linked to Higher Risks of Myocardial Infarction and Pulmonary Embolism: Study Medha Baranwal29 Aug 2024 8:00 PM ISTSweden: A recent study into chronic obstructive pulmonary disease (COPD) has unveiled a troubling correlation between the frequency and severity of...
Frequent COPD Exacerbations Linked to Increased Risk of Heart Attack and Pulmonary Embolism: Study Dr Riya Dave22 Aug 2024 5:00 AM ISTResearchers have found out that in patients with frequent acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) raise the risk of...
Alembic Pharma secures USFDA approval for Dabigatran Etexilate Capsules Ruchika Sharma13 Aug 2024 12:30 PM ISTDabigatran Etexilate Capsules 110 mg are indicated for prophylaxis of deep vein thrombosis and pulmonary embolism following hip replacement surgery.
D-dimer to fibrinogen ratio Promising Biomarker for Pulmonary Embolism Diagnosis in Postpartum Women: Study Medha Baranwal26 July 2024 9:15 PM ISTChina: A recent study published in BMC Pregnancy and Childbirth has revealed a higher diagnostic value of the D-dimer to fibrinogen ratio (DFR) than...
USFDA nod to Alembic Pharma stroke and blood clots drug Dabigatran Etexilate Ruchika Sharma19 Jun 2024 12:12 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA)...
Rare case of Fat Embolism Syndrome with Multiple Small Pulmonary Emboli After Femur Fracture ORIF: A report Dr Monish Raut11 Jun 2024 9:00 AM ISTRecently published case report discussed a case report of a 56-year-old female patient who developed Fat Embolism Syndrome (FES) and multiple small...
Novel thrombectomy system safe and feasible in treating acute pulmonary embolism: Study Dr. Kamal Kant Kohli15 May 2024 8:30 PM ISTLate-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary...
